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Caspase-2 Is Upregulated after Sciatic Nerve Transection
and Its Inhibition Protects Dorsal Root Ganglion Neurons
from Apoptosis after Serum Withdrawal
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Abstract
Sciatic nerve (SN) transection-induced apoptosis of dorsal root ganglion neurons (DRGN) is one factor determining the
efficacy of peripheral axonal regeneration and the return of sensation. Here, we tested the hypothesis that caspase-2
(CASP2) orchestrates apoptosis of axotomised DRGN both in vivo and in vitro by disrupting the local neurotrophic supply to
DRGN. We observed significantly elevated levels of cleaved CASP2 (C-CASP2), compared to cleaved caspase-3 (C-CASP3),
within TUNEL+DRGN and DRG glia (satellite and Schwann cells) after SN transection. A serum withdrawal cell culture model,
which induced 40% apoptotic death in DRGN and 60% in glia, was used to model DRGN loss after neurotrophic factor
withdrawal. Elevated C-CASP2 and TUNEL were observed in both DRGN and DRG glia, with C-CASP2 localisation shifting
from the cytosol to the nucleus, a required step for induction of direct CASP2-mediated apoptosis. Furthermore, siRNA-
mediated downregulation of CASP2 protected 50% of DRGN from apoptosis after serum withdrawal, while downregulation
of CASP3 had no effect on DRGN or DRG glia survival. We conclude that CASP2 orchestrates the death of SN-axotomised
DRGN directly and also indirectly through loss of DRG glia and their local neurotrophic factor support. Accordingly,
inhibiting CASP2 expression is a potential therapy for improving both the SN regeneration response and peripheral sensory
recovery.
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Introduction
The axons of dorsal root ganglion neurons (DRGN) transmit
sensory information from the periphery to the CNS. Although
peripheral DRGN axons regenerate, functional recovery is poor,
either because axotomy induces apoptosis in DRGN or regener-
ating axons are misrouted and re-innervate inappropriate targets.
Distinct functional as well as structural changes are observed in
DRG after PNS injury [1], including initial proliferation and
activation of satellite cells surrounding DRGN [2], up-regulation
of neurotrophic factors and neurosteroids, alteration in the
expression of neurotransmitters and apoptotic cell death of a
sub-population of DRGN and their satellite cells [3]. The extent
and severity of peripheral nerve injury determines the magnitude
of axotomised DRGN cell death. For example, after crushing the
SN most L4/L5 DRGN survive and regenerate their axons [2]
whereas, approximately 15–30% of DRGN die 30 days after
complete SN transection [2]. The survival of mature DRGN is
moderated by hyper-glycaemia, oxidative stress [4], intracellular
calcium levels [5], ionizing radiation [6] and neurosteroids [7]
although the molecular mechanisms underlying axotomy-induced
apoptosis remains unclear.
After peripheral axotomy, apoptosis of both DRGN and
Schwann cells in DRG may be mediated by CASP3 [8,9].
Although a role for CASP2 in DRGN apoptosis has not been
identified, CASP2 does mediate apoptosis in hippocampal
neurons, sympathetic neurons [10,11], retinal ganglion cells
[12], pancreatic acinar cells and insulin secreting (HIT-T15) cells
[13], cancer cells [14] and murine macrophages [15]. CASP2
triggers cell death through both intrinsic mitochondrial and
extrinsic death-receptor mediated pathways in response to death
stimuli such as heat shock [16], DNA damage [17], generation of
reactive oxygen species (ROS) [11], cytotoxic and endoplasmic
reticulum (ER) stress [18] and cytoskeletal disruption [19].
In the current study, we aimed to determine if CASP2 mediates
axotomy-induced apoptosis of SN transected adult DRGN in vivo
and in the well-established serum withdrawal in vitro model of
DRGN axotomy.
Materials and Methods
Ethics statement
This study was carried out in strict accordance to the UK
Animals Scientific Procedures Act, 1986 and all procedures were
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licensed and approved by the UK Home Office. The protocols
and experiments were also approved by the University of
Birmingham Ethical Review Sub-Committee. All surgery was
performed under inhalation anaesthesia using 5% Isofluorane
(IsoFlo, Abbott Animal Health, North Chicago, IL, USA) for
induction and 2% for maintenance. Animals were kept in
environmentally controlled animal facilities at the University of
Birmingham and every effort was made to minimise animal
suffering.
In vivo DRGN injury models
To investigate the role of CASP2 in DRGN apoptosis, SN
injury models were established as described previously [20]. SN
were transected unilaterally in adult female Sprague-Dawley rats
(150–200 g) at the level of the sacrotuberous ligament. Spontane-
ous regeneration of SN was inhibited by excising a 3 mm segment
of distal nerve stump, ligating both nerve stumps and burying the
proximal stump deep into gluteus maximus muscle. Animals were
allowed to survive for 1 month, intracardially perfused with 4%
formaldehyde (TAAB Laboratories, Peterborough, UK), the L4/
L5 DRG harvested, cryoprotected and blocked up in OCT
mounting compound (TAAB Laboratories) and stored at 220uC
until required. For all experiments, we used L5 DRG sections for
immunohistochemistry and analysis.
Immunohistochemistry
Longitudinal 15 mm thick sections of L5 DRG were cut using a
Bright cryostat (Bright Instruments, Huntingdon, UK), and
adhered onto charged glass slides and immunohistochemistry
performed as described by us previously [12,21]. Briefly, sections
were fixed in 100% ethanol, washed 63 in phosphate buffered
saline (PBS), permeabilised in PBS containing 1% Triton X-100
(Sigma, Poole, UK) and blocked in PBS containing 0.5% bovine
serum albumin (BSA) (Sigma) and 0.05% Tween 20 (PBS-T-BSA).
Sections were then incubated overnight (16–18 h) at 4uC in a
humidified chamber with the relevant primary antibody diluted
appropriately in PBS-T-BSA. CASP2 and C-CASP2 was detected
with a with polyclonal anti-rabbit antibody (Abcam, Cambridge,
UK) while C-CASP3 was detected with a rabbit polyclonal
antibody (Cell Signalling Technology, Danvers, MA, USA) while
Schwann cells were labelled with p75NTR (Sigma), all diluted at
1:200 in PBS containing BSA. Sections were then washed63 in
PBS and incubated with the relevant secondary antibody diluted
in PBS-T-BSA for 1 h at room temperature. For fluorescent
detection of the antigen, secondary antibodies were either coupled
to Alexa Fluor 488 (Green) or Texas Red (Red) (both from
Molecular Probes, Oregon, USA), and diluted at 1:400. Coverslips
were mounted in Vectamount with and without DAPI (Vector
Labs, Peterborough, UK) and viewed under a fluorescent
microscope (Carl Zeiss, Welwyn-Garden City, UK). Controls
were incubated in each run for each antibody tested, including
omission of the primary antibody and, where available, blocking
peptides were pre-incubated with the primary antibody at a ratio
of 1:20 for 2 h before incubation. Control sections showed no
positive immunohistochemistry for relevant antibodies. As a
minimum, each antibody run was performed in duplicate and
performed on 3 independent occasions using tissue sections from 6
different animals.
Images from immunohistochemistry were captured using
Axiovision Software and an AxioCam HRc attached to the
fluorescent microscope (all from Zeiss). Negative controls were
used to set the threshold level to account for background
fluorescence levels (noise) and therefore not shown.
Preparation of adult DRG cultures
Primary DRG cultures were prepared using 6–8 week-old
female Sprague-Dawley rats (150–200 g) (Charles River, Margate,
UK) killed by CO2 exposure, as described by us previously
[21,22,23]. Briefly, L4–L7 DRG pairs were dissected, dissociated
into single cells in a solution of Neurobasal-A containing 0.1%
collagenase (Sigma) and 200 U/ml DNaseI (Worthington Bio-
chem, New Jersey, USA). Dissociated DRGN were pelleted and
re-suspended in Dulbecco’s Modified Eagle Medium (DMEM)
(Invitrogen) containing 5-Flouro-2-deoxyuridine (FDU-to limit
glial proliferation) (Merck Biosciences, Feltham, UK) at a final
concentration of 30 mM and 1% Penicillin-Streptomycin (P/S),
with and without 10% fetal bovine serum (FBS) (Invitrogen) and
plated at a cell density of 300 cells/well on sterile glass chamber
slides (BD Biosciences, Oxford, UK) pre-coated with 100 mg/ml
poly-D-lysine followed by 20 mg/ml Laminin-I (both from Sigma)
and cultured for 72 h at 37uC in a humidified atmosphere
containing 5% CO2.
Immunocytochemistry
To detect DRGN survival and expression of CASP2, CASP3,
C-CASP2 and C-CASP3, cultures were fixed in 4% formaldehyde
for 10 min, washed63 in PBS, blocked in PBS-T-BSA (3% BSA
and 0.1% Triton X-100) (Invitrogen) for 10 min at room
temperature and incubated with polyclonal anti-rabbit cleaved
CASP2 (Abcam) or rabbit polyclonal C-CASP3 (Cell Signalling
Technology) and monoclonal anti-mouse bIII-tubulin (Sigma), all
diluted at 1:200 in PBS containing BSA. Cells were then washed
63 in PBS and incubated with anti-mouse Alexa Fluor 488
(Green) and anti-rabbit Alex Flour 594 (Red) (Invitrogen) diluted
1:400 in PBS-BSA for 1 h at room temperature. After the final 3
washes with PBS, cover slips were mounted in Vectamount with or
without DAPI (Vector Laboratories) and viewed under a
fluorescent microscope (Zeiss). To assess antibody specificities of
caspases, negative controls were included in each run for each
antibody tested including omission of the primary antibody.
A blinded observer divided each 8-well chamber into 9
quadrants and randomly took photomicrographs from each
quadrant using a fluorescent microscope (Zeiss) attached to a
computer running the Axiovision software (Zeiss). The observer
then counted the number of bIII-tubulin+ DRGN with DAPI
stained nuclei to assess the degree of survival in each relevant
experiment (n = 54 fields/condition). Experiments were performed
in duplicate and repeated on at least 3 independent occasions.
siRNA-mediated knockdown of CASP2 and CASP3
Dissociated DRGN were allowed to resettle for 20–24 h in
DMEM containing 30 mM FDU (Merck) with 10% FBS at 37uC
in a humidified atmosphere containing 5% CO2 prior to
transfection using Lipofectamine 2000 reagent (Invitrogen)
according to the manufacturer’s instructions for knocking down
mRNA for both CASP2 and CASP3 using 10 nM of a chemically
modified siRNA (siCASP2; Gift from Quark Pharmaceuticals,
Israel) and scrambled (Scr-siCASP2) to CASP2 mRNA [12] and
chemically synthesised siRNA (siCASP3) (anti-sense: 59–AATGG-
TACCGATGTCGATGCA–39; sense oligonucleotide: 59–AATG-
CATCGACATCGGTACCA–39 and scrambled (Scr-siCASP3;
anti-sense: AACTACGTGAGTGAGTCTGAC; sense: AAGT-
CAGACTCACTCACGTAG) targeting CASP3 mRNA (synthe-
sized by Alta Bioscience, University of Birmingham, UK).
Controls included DRG cultures transfected with Lipofectamine
alone and a non-specific siRNA to green fluorescent protein
(siGFP) (Dharmacon, Lafayette, CO, USA) and scrambled
versions of siCASP2 and siCASP3. After transfection for 5 h,
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serum free DMEM containing 30 mM FDU to limit glial cell
proliferation and acting as a potential source of neurotrophic
factors [23] was added to the transfection medium to make up the
final volume up to 500 ml/chamber. Finally DRG cultures were
incubated for a further 72 h at 37uC in a humidified atmosphere
containing 5% CO2, before either fixation in 4% formaldehyde
and subsequent immunocytochemistry (described above) or cell
lysis for western blot analysis as described in the next section. Each
knockdown experiment was performed in duplicate and repeated
on at least 3 independent occasions. Levels of knockdown were
quantified by densitometry as described in the next section.
Protein extraction, western blotting and densitometry
To determine the levels of CASP2 and -3 protein after siRNA-
mediated knockdown, DRG cultures were washed62 in PBS and
incubated in ice-cold lysis buffer containing 20 mM Tris-HCL
(pH 7.4), 1 mM EDTA, 0.5 mM EGTA, 150 mM NaCl, 1% NP-
40 (Sigma) and protease inhibitor cocktail (Sigma), incubated on
ice for 30 min, and centrifuged at 13,000 rpm at 4uC, as described
by us previously [23]. Lysates were normalised for protein using a
calorimetric DC assay kit (Bio-Rad, Hercules, CA, USA) and
10 mg of total protein were resolved on 12% SDS-polyacrylamide
gels. Proteins were transferred to PVDF membranes (Millipore,
Gloucester, UK), blocked for 1 hr and blotted overnight using the
relevant antibody. Resolved bands were detected using a enhanced
chemiluminescence (ECL) system (GE Healthcare, Buckingham-
shire, UK) and relevant HRP-conjugated secondary antibodies
(1:1000; GE Healthcare). Each blot was stripped and re-probed
with b-actin antibody as a protein loading control. Each
knockdown experiment was repeated on 3 independent occasions.
To quantify detected bands by densitometry, blots were scanned
into Photoshop (Adobe Systems, San Jose, CA, USA) and analysed
using the built-in gel plotting macros in ScionImage (Scion
Corporation, Maryland, USA) [23].
TUNEL assay and counter staining
Apoptotic DNA fragmentation was detected in tissue cryosec-
tions and DRG cultures using a fluorescent TUNEL assay kit
(Merck, Feltham, UK and Millipore, Billerica, MA, USA)
according to the manufacturer’s instructions. Briefly, after
permeabilization with Proteinase-K, cryosections were incubated
with TUNEL reaction mixture containing terminal deoxynucleo-
tidyl transferase (TdT) and dUTP coupled to fluorescein for 1 h at
37uC. Positive controls were generated using DNAase I digestion,
as described by the manufacturer. Counterstaining for C-CASP2
was performed as described under the ‘‘Immunohistochemistry’’
section with some modification in the protocol followed by the
TUNEL staining. However, for the double immunofluorescent
and TUNEL staining of DRG culture, cells were fixed with 4%
formaldehyde, permeabilized with 0.1% Triton X-100 and the rest
of the procedure was performed similarly to that described above
for immunohistochemistry. Each TUNEL assay was performed in
triplicate using sections from at least 6 different animals in each
run. TUNEL assay in cell culture was performed in duplicate and
repeated on 3 independent occasions.
Quantification of the number of TUNEL+ DRG neurons,
satellite and Schwann cells
Three sections from the mid-point of each DRG (n= 3 DRG/
treatment), determined from the total number of 15 mm-thick
sections, were stained with the TUNEL kit and used to count the
number of TUNEL+ DRGN, satellite and Schwann cell nuclei
after image capture using Image Pro software (Media Cybernetics,
Bethesda, MD, USA) in the whole DRG section. DRG glia were
defined as satellite cells if they tightly surrounded a DRGN and as
Schwann cells if spindle shaped and within the DRG neuropil un-
associated with blood vessels. The total number of DAPI stained
DRGN and DRG glia nuclei were also counted using Image Pro
(Media Cybernetics) and the number of TUNEL+ DRGN and
DRG glia were expressed as a percentage of the total number of
cells in an entire section of DRG.
Statistical analysis
Sample means were calculated and tested for significance using
ANOVA with post-hoc testing by Dunnet’s method.
Figure 1. C-CASP2 is highly induced in DRGN and satellite cells
after SN transection. A, B, Constitutive low levels of C-CASP2 and C-
CASP3 in control DRGN and satellite cells, while high levels of C-CASP2
compared to C-CASP3 were observed in DRGN and satellite cells 1
month after SN transection. C, High power magnification showing C-
CASP2 and C-CASP3 in DRGN (arrows) and satellite cells (arrowheads)
and C-CASP3 in Schwann cells (open arrowheads). Inset in (C) shows
high power magnification of double immunohistochemistry for p75NTR
and C-CASP2. Scale bar in A–C= 50 mm.
doi:10.1371/journal.pone.0057861.g001
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Results
SN transection induced up-regulation of C-CASP2 and
apoptosis of DRGN and their satellite cells
There was a constitutive low level of C-CASP2 (Figure 1A) and
C-CASP3 (Figure 1B) immunolocalisation in contralateral control
DRGN and satellite cells. Thirty days after SN transection,
enhanced C-CASP2 (Figure 1A (ii), (iii) and C) and lower levels of
C-CASP3 were localised in DRGN and satellite cells (Figure 1B).
In addition, spindle-shaped cells un-associated with blood vessels
and DRGN, morphologically identical to Schwann cells, were
strongly C-CASP3+ (Figure 1C; open arrows and inset). Ten% of
total DRGN (Figure 2A; arrows) and 30% of DRG glia (Figure 2A:
arrowheads) were TUNEL+ after SN transection (Figure 2B),
suggesting their co-dependence and that death of both types of
cells was mediated by caspase-2, while CASP3 mediated Schwann
cell death only (Figure 1C; open arrows). All TUNEL+ DRGN
(arrow) and satellite cell (arrowheads) nuclei were also C-CASP2+
(Figure 2C).
Figure 2. Apoptosis of DRGN and satellite cells at 1 month after SN transection. A, TUNEL staining in sections from contralateral control (i)
and axotomised DRGN (ii) and (iii) ((ii) shows 2 TUNEL+ DRGN nuclei, while (iii) shows TUNEL+ DRGN and DRG glia in an adjacent area)), 1 month after
SN transection. DRGN (arrows) and satellite cell (arrowheads) nuclei were TUNEL+ while contralateral DRGN and satellite cells were TUNEL2. B,
Relative percentages of TUNEL+ DRGN and DRG glia (satellite+Schwann cells) in ipsilateral and contralateral DRG after SN transection. C, Double
labelling for TUNEL and C-CASP2 in DRGN (arrows), satellite cells (arrowheads) and Schwann cells in the DRG neuropil (open arrowheads). Scale bars
in A–C=50 mm. **p,0.001, ANOVA.
doi:10.1371/journal.pone.0057861.g002
Caspase-2 Mediates DRGN Apoptosis
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Serum withdrawal activates caspase-2 and is associated
with apoptotic death of DRGN and DRG glia
To test the possibility that CASP2 is important in mediating the
death of DRGN and DRG glia, we used the serum-withdrawal
DRG cell culture model. DRGN cultured in medium containing
serum (D+S) had long neurites (Figure 3A), while those grown in
serum free medium (D2S) failed to grow neurites (Figure 3B) and
eventually died (Figure 3C). After 3 days in culture, 40% of the
total number of plated DRGN had died, rising to nearly 60% by 5
days (Figure 3C). DRG glia were more susceptible to death
induced by serum withdrawal and, by 3 days in culture, .60% of
the total number of cells had died (Figure 3D). These results
demonstrated that serum withdrawal caused a time-dependent
decrease in DRGN survival and neurite outgrowth together with
death of DRG glia. Hence, exogenous trophic support is required
for DRGN survival and neurite outgrowth and also for DRG glia
survival.
Figure 3. Survival of DRGN after 5 days in culture, in the
presence of serum and after serum withdrawal. DRGN grown in
A, presence of serum (D+S) or, B, after serum withdrawal (D2S). C,
DRGN and D, DRG glia survival in the presence of serum and after
serum withdrawal, over time in culture. The data presented here are
means6SEM from 3–5 separate experiments conducted in duplicate.
doi:10.1371/journal.pone.0057861.g003
Figure 4. CASP2 is activated in serum-withdrawn DRGN and
satellite cells. A, CASP2, C-CASP2 and B, CASP3, C-CASP3 in DRGN and
satellite cells grown in the presence of serum (D+S) or after serum
withdrawal (D2S). C, Double immunostaining for C-CASP2 in bIII-
tubulin+ DRGN (arrow) and C-CASP2+ in bIII-tubulin2 satellite cells
(arrowheads). Scale bars in A–C= 50 mm.
doi:10.1371/journal.pone.0057861.g004
Caspase-2 Mediates DRGN Apoptosis
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Localisation of CASP-2, -3, C-CASP-2 and -3 and TUNEL in
both DRGN and satellite cells
Serum withdrawal increased CASP2 and C-CASP2 levels in
DRGN (Figure 4A), while little or no change in either CASP3 or
C-CASP3 (Figure 4B) was detected in serum starved compared to
serum nurtured DRGN. There was little or no C-CASP2+ staining
in either DRGN or DRG glia grown in the presence of serum
(D+S) (Figure 4C). However, after serum withdrawal (D2S), C-
CASP2 levels rose in DRGN (arrow) and their associated satellite
cells (arrowheads) (Figure 4C). C-CASP2 and C-CASP3 in DRGN
were localised to within either the cytosol (Figure 5A(i)), nucleus
(Figure 5A(ii)) or in both compartments (Figure 5A(iii)). DRGN
numbers fell after serum withdrawal and correlating with a
concomitant 50% increase in nuclear C-CASP2 localisation
(Figure 5B). Immunostaining for C-CASP3 on the other hand,
was weak in DRGN cytosol and nucleus and no obvious
differences in the intracellular localisation were observed between
serum-withdrawn (D2S) and serum fed DRGN (D+S) (Figure 6).
These data in an in vitro paradigm of exogenous neurotrophic
factor deprivation in DRGN, suggest that serum withdrawal
causes activation of CASP2 and not CASP3 in DRGN and
satellite cells. Greater numbers of DRGN and their satellite cells
were TUNEL+ after serum withdrawal (D2S) than those grown in
the presence of serum (D+S) (Figure 7A and 7B).
siRNA meditated knockdown of CASP2, but not CASP3,
rescued DRGN and DRG glia from apoptosis
Since elevated levels of CASP2 were seen in cultured adult
DRGN and DRG glia after serum withdrawal, we used siRNA-
mediated gene silencing of CASP2 and CASP3 to determine
which of these protected DRGN from death after serum
withdrawal. Approximately 65% and 75% gene silencing was
achieved in DRG cultures after siCASP2 and siCASP3 treatment,
respectively (Figure 8A and 8B). Lipofectamine, Scr-siCASP2 and
Scr-siCASP3 control transfections did not affect either CASP2 or
CASP3 protein levels, demonstrating the specificity of the siRNA
sequences (Figure 8A and 8B). Knockdown of the relevant protein
in DRG cultures also reduced immunohistochemical levels of
CASP2 and -3 in DRGN and DRG glia after relevant siRNA
treatments (Figure 8C and 8D). Knockdown of CASP2 mRNA by
RNAi protected 50% of both DRGN (Figure 8E) and DRG glia
(Figure 8F) from apoptosis induced by serum withdrawal, while
knockdown of CASP3 had no effect. These results suggest that
CASP2 and not CASP3 orchestrates DRGN and DRG glia
apoptosis in in vitro after serum withdrawal.
Discussion
A greater frequency of immature DRGN undergo axotomy-
and NGF-induced apoptotic cell death compared to adult DRGN
[24]. However, it is noteworthy that, despite the ability of sensory
neurons to regenerate axons, experimentally induced chronic
sciatic nerve injuries cause significant levels of death of adult
DRGN and incomplete functional recovery [2,20,25]. Approxi-
mately 40% of DRGN die within 2 months in animal models of
peripheral axotomy and a similar loss is also observed clinically;
indicating that the death of sensory neurons is one of the key
determinants for the poor sensory recovery after SN injury
[2,20,25]. Although the molecular mechanisms underlying
axotomy-induced DRGN death are not fully understood, the
extent and severity of the axonal injuries and the loss of available
target-derived exogenous trophic factors are believed to signifi-
cantly impact on apoptosis and the potential for axon regrowth
[25,26]. Despite the fact that mature sensory neurons are less
dependent than immature neurons upon trophic support for their
survival, neurotrophins still regulate survival and axon regenera-
tion after injury [27]. In clinical situations where target re-
innervation is delayed or absent (e.g. brachial plexus lesions),
substantial DRGN apoptosis is a likely scenario [28,29]. Our
model of SN transection and blockade of invasion of the distal
nerve stump mimics this and induces similar DRGN loss. In this
study, we investigated the role of CASP2 in axotomy-induced
DRGN apoptosis, by limiting the exogenous availability of target-
derived neurotrophic factors.
Consistent with the study of Hart and co-workers (2002) [29],
we observed a similar magnitude of DRGN death (10%), 1 month
after SN transection, accompanied by 30% loss of DRG glia. In
our SN transection model, the combined TUNEL- and immuno-
staining with antibodies against C-CASP2 and C-CASP3 revealed
co-activation of CASP2 only, correlating with DRGN, satellite cell
Figure 5. Localisation of C-CASP2 to the cytosol, nucleus, and
to both compartments either in the presence of serum or after
serum withdrawal. The patterns of C-CASP2 immunocytochemistry
included cytosolic (arrow) but not nuclear expression (open arrowhead)
A(i), nuclear (closed arrowhead) A(ii), or cytosolic (arrow) and nuclear
(arrowhead) A(iii). B, Percentage frequency of DRGN with either
cytosolic, nuclear or cytosolic+nuclear localisation of C-CASP2 in the
presence of serum (D+S) and after serum withdrawal (D2S). Scale
bar = 50 mm.
doi:10.1371/journal.pone.0057861.g005
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and Schwann cell apoptosis. Levels of C-CASP2 were much
higher than C-CASP3 in DRGN and DRG glia, suggesting that
CASP2 may have the more significant role in the apoptotic
cascade. Despite the fact that many different DRGN reside in the
DRG, characterised by parameters such as neuronal size, target
profile and whether myelinated or unmeyelinated [30,31], almost
all DRGN showed raised C-CASP2 and were C-CASP2+. This
suggests that all sizes of DRGN were similarly affected by trophic
factor withdrawal. In addition, the 30% increase in TUNEL+
satellite cells around dying DRGN indicated an inter-dependence
of satellite cells with DRGN, linking satellite cell survival with
axotomised DRGN by restricting the supply of local neurotrophic
factors [2,7].
The observed survival inter-dependence of DRGN and satellite
cells suggest that signals retrogradely transported in DRGN axons
are a regulatory stimulus for the satellite cell integrity underlying
DRGN-satellite cell interactions. Satellite cells typically regulate
the embryonic development of DRGN and continue to exert a
trophic influence into adulthood, though the underlying mecha-
nism remains to be elucidated [32]. The intimacy of satellite cell/
DRGN interrelationships is refined by the reciprocal projection of
micro-villi from each cell deep into the respective cytoplasm of the
other [33]. Indeed, Schaeffer and colleagues (2010) [7] proposed,
after a chronic SN constriction injury that selectively activates
apoptosis of satellite cells, the existence of either a paracrine or a
cross-talk mechanism in apoptotic satellite cells which activates
pro-survival factors in associated DRGN. Therefore, we suggest
that the loss of target-derived neurotrophic factors combined with
depletion of satellite cell-derived local trophic support [34] are key
determinants of DRGN apoptosis and probably contribute to the
DRGN loss.
To further investigate the role of CASP2 in DRGN and DRG
glia apoptosis, we have used a well-established in vitro DRG model
that provides a mixed population of axotomised adult DRGN and
DRG glia that undergo apoptosis when serum is withdrawn. This
primary cell culture model mimics the loss of target-derived
neurotrophic factors experienced by DRGN after a procedure that
transects the SN and prevents re-innervation. Our in vitro serum-
withdrawal model detected significant levels of C-CASP2 in
TUNEL+ DRGN and DRG glia consistent with our in vivo
observations, linking DRGN and DRG glia death with CASP2.
Although earlier reports suggest that CASP2 is processed after a
variety of stimuli but was not required for death of sensory DRGN
[35], these studies were performed in postnatal 2-day old rats,
which are NGF-dependent for their survival. This is contrast to
our current study where we use adult DRGN, which are
independent of NGF for their survival and generally less reliant
on trophic support [27] and show that DRGN death is regulated
by CASP2 in both in vivo and in vitro serum withdrawal paradigms.
Furthermore, we found little or no C-CASP3 immunoreactivity in
serum-starved DRGN, while an abundance of C-CASP2 immu-
noreactivity was observed in these neurons, further vindicating our
assertion that CASP2 is the major caspase responsible for death of
DRGN after neurotrophic factor withdrawal.
The sub-cellular localization of C-CASP2 and the mechanism
of activation of CASP2 may be linked and differs from cell type
and death stimulus. Although the majority of CASP2 is found in
the cytoplasm [36] some contradictory findings report that pro-
CASP2 is localized to both cytoplasm and nucleus and that
processing occurs in both compartments. CASP2 is constitutively
localised to the nucleus by interaction of its nuclear localization
signal with both its prodomain signal and the importin mediator
[36,37]. Our results are consistent with these observations since
they demonstrate that, although C-CASP2 is both nuclear and
cytoplasmic in DRGN, significantly greater levels were detected in
the nucleus after serum withdrawal. Colussi and co-workers (1998)
Figure 6. High power images demonstrating immunostaining for C-CASP3 and its localization in cytosol and nucleus. C-CASP3
localisation in DRGN grown in both the presence of serum (D+S) and after serum withdrawal (D2S). Scale bar = 50 mm.
doi:10.1371/journal.pone.0057861.g006
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[36] also reported that CASP2 was localised in the cytoplasm,
mitochondria and nuclei of normal Jurkat cells, while C-CASP2
was only present in the nucleus of apoptotic cells. Thus the nucleus
appears to be the site of CASP2 cleavage and activation, both of
which remain nuclear even after the induction of cell death [38].
Of potential translational importance, we have also demon-
strated that silencing of CASP2 expression by siRNA-mediated
knockdown of CASP2 mRNA protected DRGN from apoptosis
after serum withdrawal. By contrast, CASP3 knockdown failed to
rescue DRGN from apoptosis. Therefore, we suggest that CASP2
plays a major role in the execution of apoptosis in axotomised
adult DRGN after neurotrophic factor depletion. Despite CASP2
sharing features of both initiator and effector caspases, processed
rapidly in response to both intra- and extra-cellular signalling
events occurring early during apoptosis in many cell types
[39,40,41], its role in apoptosis has been contentious. For example,
O’Reilly et al. (2002) [35] reported that DRGN in postnatal 2 day-
old CASP-2 deficient mice did not die after NGF withdrawal.
However, this contradicts another study, which reported that
decreasing CASP-2 levels by anti-sense technology, delayed
apoptosis induced by trophic factor deprivation in sympathetic
neurons [42]. Others have also shown that CASP2 triggers
apoptosis of serum-deprived PC12 cells and cortical neurons,
while CASP2 inhibitors and siRNA-mediated knock down of
CASP2 protects these neurons from death induced by serum
deprivation [43,44]. Our current results however, agree with the
vast body of evidence that suggest that CASP2 regulates the death
of DRGN.
In conclusion, we have demonstrated an interdependence of
DRGN and DRG survival and a link between the activation of
CASP2 and apoptosis in vivo and in vitro. Taken together, our data
support the notion that CASP2, not CASP3, plays both a direct
and indirect role in DRGN death. These studies provide valuable
insight into the fundamental mechanisms underlying axotomy-
induced apoptosis of DRGN and implicate a role for both target-
and satellite cell-derived neurotrophic factors in their normal
Figure 7. TUNEL staining in 3 day DRG cultures grown in DMEM in the presence of serum (D+S) and after serum withdrawal (D2S).
A, TUNEL+ DRGN in the presence of serum (D+S) or after serum withdrawal (D2S). B, DRGN grown in the absence of serum (D2S) demonstrating
TUNEL+ nuclei of both DRGN (arrow) and satellite cells (arrowheads). Scale bars in A and B= 50 mm.
doi:10.1371/journal.pone.0057861.g007
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physiology. They further suggest the therapeutic utility of CASP2
silencing after PN axotomy.
Acknowledgments
The authors are grateful to Quark Pharmaceuticals Inc, Israel for
providing the stable modified siCASP2 and Scr-siCASP2 used in this study.
Author Contributions
Conceived and designed the experiments: MB AL ZA. Performed the
experiments: VV MB ZA. Analyzed the data: VV ZA. Contributed
reagents/materials/analysis tools: MB. Wrote the paper: VV MB AL ZA.
References
1. Guseva D, Chelyshev Y (2006) The plasticity of the DRG neurons belonging to
different subpopulations after dorsal rhizotomy. Cell Mol Neurobiol 26: 1225–
1234.
2. Arkhipova SS, Raginov IS, Mukhitov AR, Chelyshev YA (2010) Satellite cells of
sensory neurons after various types of sciatic nerve trauma in the rat. Neurosci
Behav Physiol 40: 609–614.
Figure 8. CASP2 knockdown protects DRGN and DRG glia from apoptosis induced by serum withdrawal. A, Western blot and B,
subsequent densitometry to show CASP2 and CASP3 protein levels after knockdown with relevant siRNA. C, and D, Immunocytochemistry to
demonstrate CASP2 and CASP3 knockdown in DRGN and satellite cells by relevant siRNA, respectively. E, Quantification of DRGN and F, DRG glia
survival after siRNA-mediated knockdown of CASP2 and CASP3. Scale bars in C and D=50 mm.
doi:10.1371/journal.pone.0057861.g008
Caspase-2 Mediates DRGN Apoptosis
PLOS ONE | www.plosone.org 9 February 2013 | Volume 8 | Issue 2 | e57861
3. Raginov IS, Chelyshev YA (2005) Post-traumatic survival of sensory neurons of
different subpopulations. Neurosci Behav Physiol 35: 17–20.
4. Vincent AM, Russell JW, Low P, Feldman EL (2004) Oxidative stress in the
pathogenesis of diabetic neuropathy. Endocr Rev 25: 612–628.
5. Tong JX, Eichler ME, Rich KM (1996) Intracellular calcium levels influence
apoptosis in mature sensory neurons after trophic factor deprivation. Exp Neurol
138: 45–52.
6. Tong JX, Vogelbaum MA, Drzymala RE, Rich KM (1997) Radiation-induced
apoptosis in dorsal root ganglion neurons. J Neurocytol 26: 771–777.
7. Schaeffer V, Meyer L, Patte-Mensah C, Eckert A, Mensah-Nyagan AG (2010)
Sciatic nerve injury induces apoptosis of dorsal root ganglion satellite glial cells
and selectively modifies neurosteroidogenesis in sensory neurons. Glia 58: 169–
180.
8. Janicke RU, Sprengart ML, Wati MR, Porter AG (1998) Caspase-3 is required
for DNA fragmentation and morphological changes associated with apoptosis.
The Journal of biological chemistry 273: 9357–9360.
9. Saito H, Kanje M, Dahlin LB (2009) Delayed nerve repair increases number of
caspase 3 stained Schwann cells. Neuroscience letters 456: 30–33.
10. Stefanis L, Troy CM, Qi H, Greene LA (1997) Inhibitors of trypsin-like serine
proteases inhibit processing of the caspase Nedd-2 and protect PC12 cells and
sympathetic neurons from death evoked by withdrawal of trophic support.
J Neurochem 69: 1425–1437.
11. Troy CM, Rabacchi SA, Friedman WJ, Frappier TF, Brown K, et al. (2000)
Caspase-2 mediates neuronal cell death induced by beta-amyloid. J Neurosci 20:
1386–1392.
12. Ahmed Z, Kalinski H, Berry M, Almasieh M, Ashush H, et al. (2011) Ocular
neuroprotection by siRNA targeting caspase-2. Cell Death Dis 2: e173.
13. Madro A, Korolczuk A, Czechowska G, Celinski K, Slomka M, et al. (2008)
RAS inhibitors decrease apoptosis of acinar cells and increase elimination of
pancreatic stellate cells after in the course of experimental chronic pancreatitis
induced by dibutyltin dichloride. J Physiol Pharmacol 59 Suppl 2: 239–249.
14. Gao Z, Shao Y, Jiang X (2005) Essential roles of the Bcl-2 family of proteins in
caspase-2-induced apoptosis. J Biol Chem 280: 38271–38275.
15. Chen F, He Y (2009) Caspase-2 mediated apoptotic and necrotic murine
macrophage cell death induced by rough Brucella abortus. PLoS One 4: e6830.
16. Pagliari LJ, Kuwana T, Bonzon C, Newmeyer DD, Tu S, et al. (2005) The
multidomain proapoptotic molecules Bax and Bak are directly activated by heat.
Proc Natl Acad Sci USA 102: 17975–17980.
17. Zhivotovsky B, Orrenius S (2005) Caspase-2 function in response to DNA
damage. Biochem Biophys Res Commun 331: 859–867.
18. Cao X, Bennett RL, May WS (2008) c-Myc and caspase-2 are involved in
activating Bax during cytotoxic drug-induced apoptosis. J Biol Chem 283:
14490–14496.
19. Ho LH, Read SH, Dorstyn L, Lambrusco L, Kumar S (2008) Caspase-2 is
required for cell death induced by cytoskeletal disruption. Oncogene 27: 3393–
3404.
20. McKay Hart A, Brannstrom T, Wiberg M, Terenghi G (2002) (B) Primary
sensory neurons and satellite cells after peripheral axotomy in the adult rat:
timecourse of cell death and elimination. Exp Brain Res 142: 308–318.
21. Ahmed Z, Jacques SJ, Berry M, Logan A (2009) Epidermal growth factor
receptor inhibitors promote CNS axon growth through off-target effects on glia.
Neurobiology of disease 36: 142–150.
22. Ahmed Z, Dent RG, Suggate EL, Barrett LB, Seabright RJ, et al. (2005)
Disinhibition of neurotrophin-induced dorsal root ganglion cell neurite
outgrowth on CNS myelin by siRNA-mediated knockdown of NgR, p75NTR
and Rho-A. Molecular and cellular neurosciences 28: 509–523.
23. Ahmed Z, Read ML, Berry M, Logan A (2010) Satellite glia not DRG neurons
constitutively activate EGFR but EGFR inactivation is not correlated with axon
regeneration. Neurobiology of disease 39: 292–300.
24. Lin CR, Yang CH, Huang CE, Wu CH, Chen YS, et al. (2011) GADD45A
protects against cell death in dorsal root ganglion neurons following peripheral
nerve injury. J Neurosci Res 89: 689–699.
25. Gordon T, Tyreman N, Raji MA (2011) The basis for diminished functional
recovery after delayed peripheral nerve repair. J Neurosci 31: 5325–5334.
26. Wood MD, Kemp SW, Weber C, Borschel GH, Gordon T (2011) Outcome
measures of peripheral nerve regeneration. Ann Anat 193: 321–333.
27. Song XY, Li F, Zhang FH, Zhong JH, Zhou XF (2008) Peripherally-derived
BDNF promotes regeneration of ascending sensory neurons after spinal cord
injury. PLoS One 3: e1707.
28. Terenghi G, Hart A, Wiberg M (2011) The nerve injury and the dying neurons:
diagnosis and prevention. The Journal of hand surgery, European volume 36:
730–734.
29. Hart AM, Terenghi G, Wiberg M (2008) Neuronal death after peripheral nerve
injury and experimental strategies for neuroprotection. Neurological research
30: 999–1011.
30. Jancso G (1992) Pathobiological reactions of C-fibre primary sensory neurones
to peripheral nerve injury. Experimental physiology 77: 405–431.
31. Aldskogius H, Arvidsson J, Grant G (1985) The reaction of primary sensory
neurons to peripheral nerve injury with particular emphasis on transganglionic
changes. Brain research 357: 27–46.
32. Hanani M (2005) Satellite glial cells in sensory ganglia: from form to function.
Brain research Brain research reviews 48: 457–476.
33. Pannese E (2010) The structure of the perineuronal sheath of satellite glial cells
(SGCs) in sensory ganglia. Neuron glia biology 6: 3–10.
34. Wetmore C, Olson L (1995) Neuronal and nonneuronal expression of
neurotrophins and their receptors in sensory and sympathetic ganglia suggest
new intercellular trophic interactions. The Journal of comparative neurology
353: 143–159.
35. O’Reilly LA, Ekert P, Harvey N, Marsden V, Cullen L, et al. (2002) Caspase-2 is
not required for thymocyte or neuronal apoptosis even though cleavage of
caspase-2 is dependent on both Apaf-1 and caspase-9. Cell death and
differentiation 9: 832–841.
36. Colussi PA, Harvey NL, Kumar S (1998) Prodomain-dependent nuclear
localization of the caspase-2 (Nedd2) precursor. A novel function for a caspase
prodomain. J Biol Chem 273: 24535–24542.
37. Kumar S (2009) Caspase 2 in apoptosis, the DNA damage response and tumour
suppression: enigma no more? Nat Rev Cancer 9: 897–903.
38. Vakifahmetoglu H, Olsson M, Tamm C, Heidari N, Orrenius S, et al. (2008)
DNA damage induces two distinct modes of cell death in ovarian carcinomas.
Cell Death Differ 15: 555–566.
39. Lamkanfi M, Declercq W, Kalai M, Saelens X, Vandenabeele P (2002) Alice in
caspase land. A phylogenetic analysis of caspases from worm to man. Cell Death
Differ 9: 358–361.
40. Kumar S, Vaux DL (2002) Apoptosis. A cinderella caspase takes center stage.
Science 297: 1290–1291.
41. Tu S, McStay GP, Boucher LM, Mak T, Beere HM, et al. (2006) In situ
trapping of activated initiator caspases reveals a role for caspase-2 in heat shock-
induced apoptosis. Nat Cell Biol 8: 72–77.
42. Troy CM, Stefanis L, Greene LA, Shelanski ML (1997) Nedd2 is required for
apoptosis after trophic factor withdrawal, but not superoxide dismutase (SOD1)
downregulation, in sympathetic neurons and PC12 cells. The Journal of
neuroscience : the official journal of the Society for Neuroscience 17: 1911–
1918.
43. Haviv R, Lindenboim L, Yuan J, Stein R (1998) Need for caspase-2 in apoptosis
of growth-factor-deprived PC12 cells. J Neurosci Res 52: 491–497.
44. Chauvier D, Lecoeur H, Langonne A, Borgne-Sanchez A, Mariani J, et al.
(2005) Upstream control of apoptosis by caspase-2 in serum-deprived primary
neurons. Apoptosis 10: 1243–1259.
Caspase-2 Mediates DRGN Apoptosis
PLOS ONE | www.plosone.org 10 February 2013 | Volume 8 | Issue 2 | e57861
